APPLICATION
ANDA208809
TYPE
ANDA
ORIGINAL APPROVAL
2017-07-06
LATEST ACTION
2026-06-18
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
MORPHINE SULFATEDiscontinued
MORPHINE SULFATE 100MG/5ML · SOLUTION · ORAL
Approval history
2026-06-18REMS · Supplement 10AP
2024-10-31REMS · Supplement 8AP
2020-02-10Labeling · Supplement 5 · standardAP
2020-02-10Labeling · Supplement 2 · standardAP
2018-09-18REMS · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.